Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine plus ropivacaine for ultrasound-guided brachial plexus block in upper limb surgery
ChiCTR2300071534Phase 4Not yet recruiting
- Sponsor
- Renmin Hospital, Hubei University of Medicine
- Start
- May 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine and ropivacaine in perioperative pain (3 arms), sponsored by Renmin Hospital, Hubei University of Medicine. Primary endpoint: Duration of sensory nerve block. Planned start May 2023; status: not yet recruiting.
02
Drugs
esketamineropivacaine
03
Conditions
perioperative pain
Beyond the preview
Go deeper on ChiCTR2300071534.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300071534.